This month’s Digital Health Videocast sees us sit down with Brian Dolan, Founder and lead writer of Exits & Outcomes (E&O), following the highly successful launch of our latest industry report ‘Prescription Digital Therapeutics (PDT) The Future of Digital Therapeutics’ co-created by HealthXL and E&O

This week we launched our 50-page Prescription Digital Therapeutics (PDT) Report. The report was created in collaboration with Brian Dolan of Exits & Outcomes (E&O). This report contains key examples of PDT applications, industry implications and a critical viewpoint; find out more in this blog.

We are excited to give you a sneak peek into our upcoming report on Prescription Digital Therapeutics. 

In our latest podcast we are talking to Francesca Wuttke, Chief Digital Officer at Almirall.

Slowly we are seeing payers embrace the true value and potential of digital and yet, it is difficult to ascertain to what extent leading insurers are actually engaging with digital. With this in mind we assessed the digital health maturity of leading plans in the United States.

We looked at how companies interact with each other, and work together in different capacities depending on where along the digital health maturity journey they are.

Our Quarterly research report is now Live! This quarter, we assessed the digital health maturity of the Top 10 pharmaceutical companies (by revenue) over the past 5 years in the following four areas - investment, acquisition, partnerships, and hiring initiatives. 

Our report on Virtual Health Assistants (VHA). The report looks at the investment landscape, clinical evidence, and regulatory environment for VHAs, and also explores end-user feedback and case studies looking at both the positives and negatives of VHAs.

The new wave in the industry is Digital Therapeutics (DTx). The term came into existence under the premise that mobile software can be effective medical treatments. DTx certainly seem to exhibit a superiority above all the 'banal' digital health solutions, but is the promise real?

The European Digital Health Investment includes key insights and perspectives from leaders in investment to help set the scene for those looking to ignite the European digital health space or simply understand how it compares to our US counterparts.

An insider view into the partnership and investment approach of Boston Children's Hospital. Read more for 3 key lessons from their leading innovation team and learn more about one of their investment success stories.

Securing relationships with payors is often stated as a must for digital health companies looking to gain credibility and scale. The inevitable question arises 'who is going to pay for this and why?'

In Part 2 of this report, we investigate some of the recently failed digital health efforts and ascertain the lessons we should learn from them.

Is digital health merely a big collection of pilots; a good thing to talk about and a cool thing to have? What constitutes success in the world of health technology? Does a multi million-dollar investment mean we’re getting somewhere?

We are being firmly nudged to seriously consider the role digital solutions can play in increasing quality of life and independence for aging populations. Our reports looks how new aged care models can help.

Our report on Artificial Intelligence that focuses on select AI applications in the following areas: life sciences, care delivery, payor & consumer.